Alnylam Pharmaceuticals reported $2.68B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Avrobio Inc AVRO:US 211.66M 21.86M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NVS:US $ 26253M 2445M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Takeda 4502:JP Y 2456353M 20105M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Xencor XNCR:US $ 329.63M 151.34M
YTE INCY:US $ 2923.8M 303.74M